corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 14199

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Manhattan Research Announces Top 10 Product Sites Visited by Physicians
Manhattan Research 2008 Aug 25
http://www.manhattanresearch.com/newsroom/Press_Releases/top-pharma-product-websites-2008.aspx


Abstract:

Diabetes sites gain popularity as treatment options change


Full text:

Diabetes treatment brand sites from Januvia, Actos, Byetta, and Avandia are among the top pharmaceutical product websites in terms of primary care physician visitation, according to a new study from pharmaceutical and healthcare market research company Manhattan Research.

Breaking into this year’s top product site list are Actos, Actonel, Amitiza, and Aciphex, proving to be successful in increasing physician awareness online. Other brands with sites that made strides in physician visitation are Chantix, jumping from the fourth to third position, and Gardasil, moving up three spots from last year’s list.

Top 10 Pharma Product Websites among Physicians in 2008
Ranked by Number of U.S. Primary Care Physician Visitors
Position Product
1. Januvia
2. Actos
3. Chantix
4. Gardasil
5. Actonel
6. Vytorin
7. Amitiza
8. Byetta
9. Avandia
10. Aciphex

Source: ePharma Physician® v8.0 (2008)

“This year’s rankings show that market events, rather than just advertising alone, can be critical drivers to brand websites,” points out Meredith Abreu Ressi, VP of Research at Manhattan Research. “Pharmaceutical companies need to ensure that brand websites contain the latest, most accurate content possible and can be found relatively easily by physicians using search engines to research pharmaceutical information.”

The ePharma Physician® v8.0 study and its accompanying advisory service focus on physician usage and opinions of online pharmaceutical and biotech information and feature data on a broad spectrum of life sciences companies including GlaxoSmithKline, Johnson & Johnson, Pfizer, Teva, UCB, Amgen, and Watson.

ePharma Physician® v8.0 Webcast

Marketers interested in learning more about the latest digital sales and professional marketing trends are invited to attend a webcast from Manhattan Research on August 26. The session is a must-attend event for healthcare and pharmaceutical marketers looking to effectively reach physician audiences through CRM, tech-enabled sales forces, interactive detailing, Web 2.0, pharmaceutical customer service portals, and other strategies.

Date & Time: Tuesday, August 26, 2008 at 11am and 3pm, EDT
Register Now: Enroll online at manhattanresearch.webex.com

About ePharma Physician® v8.0

ePharma Physician® v8.0 was conducted via online survey methodology in Q2 2008 among 1,681 online practicing U.S. physicians.

For seven consecutive years, the study has determined the leading online physician destinations based on the number of physician visitors as well as the content satisfaction of those who visit. In-depth analysis of top product and corporate pharmaceutical websites, health portals, online journal sites, specialty-specific sites, newsletters and society sites is available as part of the ePharma Physician® v8.0 advisory service.

ePharma Physician® v8.0 also includes the following specialist segments in the research: Allergy and Immunology, Cardiology (Cardiovascular Surgery and Interventional Cardiology), Dermatology, Emergency Medicine, Endocrinology, Family Medicine/General Practice, Gastroenterology, Infectious Disease or HIV physician, Internal Medicine, Nephrology, Neurology, OB/GYN, Oncology-Hematology & Medical, Ophthalmology, Pediatrics, Psychiatry, Pulmonology, Radiology, Rheumatology, Surgery (General and Orthopedic), and Urology.

Key Research Topics Covered
ePharma Physician® v8.0 research reveals insight into the following:
• Interactive Detailing and Technology-Assisted Detailing
• Top Online Resources
• Web 2.0 Technologies
• Email Use and Interest
• Pharmaceutical Customer Service Portals
• Top Product and Corporate Websites

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909